TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T82795	Beta-catenin	D0S6XD	Calphostin C	Terminated	10930781	C44H38O14	790.8	C[C@H](CC1=C2C3=C(C(=C(C4=C3C(=C5C2=C(C(=O)C=C5OC)C(=C1OC)O)C(=CC4=O)OC)O)OC)C[C@@H](C)OC(=O)OC6=CC=C(C=C6)O)OC(=O)C7=CC=CC=C7	IC50 = 77000 nM	Poor binder
T82795	Beta-catenin	B34FYB	CCOC(=O)Cn1c2ccccc2c2nc3nonc3nc12	Investigative	122180636	C14H11N5O3	297.27	CCOC(=O)CN1C2=CC=CC=C2C3=NC4=NON=C4N=C31	Ki = 63000 nM	Poor binder
T82795	Beta-catenin	B3MTN2	5H-[1,2,5]Oxadiazolo[3',4':5,6]pyrazino[2,3-b]indole	Investigative	684781	C10H5N5O	211.18	C1=CC2=C3C(=NC4=NONC4=N3)N=C2C=C1	Ki = 120000 nM	Poor binder
T82795	Beta-catenin	B3V1BP	1-Hydroxy-5-(2H-tetrazol-5-ylmethoxy)benzotriazole	Investigative	71695708	C8H7N7O2	233.19	C1=CC2=C(C=C1OCC3=NNN=N3)N=NN2O	Ki = 50400 nM	Poor binder
T82795	Beta-catenin	B4X6OP	CCOC(=O)CCCn1c2ccccc2c2nc3nonc3nc12	Investigative	122180640	C16H15N5O3	325.32	CCOC(=O)CCCN1C2=CC=CC=C2C3=NC4=NON=C4N=C31	Ki = 52000 nM	Poor binder
T82795	Beta-catenin	B5Q2BR	(5Z)-5-{[2,5-Dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene}-3-phenyl-1,3-thiazolidine-2,4-dione	Investigative	5967294	C21H17N3O2S	375.4	CC1=CC(=C(N1C2=CN=CC=C2)C)/C=C\\3/C(=O)N(C(=O)S3)C4=CC=CC=C4	Ki = 53510 nM	Poor binder
T82795	Beta-catenin	B5RUP8	3-[(1-Hydroxybenzotriazol-5-yl)methyl]-2H-1,2,4-oxadiazole-5-thione	Investigative	71695703	C9H7N5O2S	249.25	C1=CC2=C(C=C1CC3=NC(=S)ON3)N=NN2O	Ki = 105900 nM	Poor binder
T82795	Beta-catenin	B5U4CY	Icrt3	Investigative	6622273	C23H26N2O2S	394.5	CCC1=CC=C(C=C1)C2=NC(=C(O2)C)CSCC(=O)NCCC3=CC=CC=C3	Ki = 195470 nM	Poor binder
T82795	Beta-catenin	B9BU4G	2-Phenoxybenzamide	Investigative	3290567	C13H11NO2	213.23	C1=CC=C(C=C1)OC2=CC=CC=C2C(=O)N	Ki = 180990 nM	Poor binder
T82795	Beta-catenin	B9PN4R	Nc1nonc1NC(=O)Cn1c2ccccc2c2nc3nonc3nc12	Investigative	122180635	C14H9N9O3	351.28	C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3N2CC(=O)NC5=NON=C5N	Ki = 88000 nM	Poor binder
T82795	Beta-catenin	BAOK04	4-(13-Oxa-8,10,12,14,16-pentazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11,14-heptaen-8-yl)butanoic acid	Investigative	122180708	C14H11N5O3	297.27	C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3N2CCCC(=O)O	Ki = 59000 nM	Poor binder
T82795	Beta-catenin	BAYH54	Nc1nonc1C(=O)N\\N=C1\\c2ccccc2-c2nc3nonc3nc12	Investigative	1749091	C14H7N9O3	349.26	C1=CC=C2C(=C1)C(=C3C2=NC4=NONC4=N3)N=NC(=O)C5=NON=C5N	IC50 = 52000 nM	Poor binder
T82795	Beta-catenin	BCT32M	3-[2-(1-Hydroxyindazol-5-yl)ethyl]-2H-1,2,4-oxadiazol-5-one	Investigative	136268334	C11H10N4O3	246.22	C1=CC2=C(C=C1CCC3=NOC(=O)N3)C=NN2O	Ki = 97700 nM	Poor binder
T82795	Beta-catenin	BGK6F8	C(Cc1nn[nH]n1)Cn1c2ccccc2c2nc3nonc3nc12	Investigative	122180713	C14H11N9O	321.3	C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3N2CCCC5=NNN=N5	Ki = 51000 nM	Poor binder
T82795	Beta-catenin	BK84EV	C(Cn1c2ccccc2c2nc3nonc3nc12)c1nn[nH]n1	Investigative	122180712	C13H9N9O	307.27	C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3N2CCC5=NNN=N5	Ki = 53000 nM	Poor binder
T82795	Beta-catenin	BLD6T1	5-[4-(4-Chlorophenoxy)phenyl]-3-isoxazolecarboxylic acid	Investigative	71625260	C16H10ClNO4	315.71	C1=CC(=CC=C1C2=CC(=NO2)C(=O)O)OC3=CC=C(C=C3)Cl	Ki = 77000 nM	Poor binder
T82795	Beta-catenin	BM3FU1	N-(1-Hydroxyindazol-5-yl)-N-(2H-tetrazol-5-ylmethyl)pyridine-3-carboxamide	Investigative	71695834	C15H12N8O2	336.31	C1=CC(=CN=C1)C(=O)N(CC2=NNN=N2)C3=CC4=C(C=C3)N(N=C4)O	Ki = 179930 nM	Poor binder
T82795	Beta-catenin	BN1C2F	4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid	Investigative	1416325	C16H17NO5S2	367.4	COC1=C(C=C(C=C1)/C=C\\2/C(=O)N(C(=S)S2)CCCC(=O)O)OC	Ki = 80340 nM	Poor binder
T82795	Beta-catenin	BOD02S	3-[2-(1-Hydroxyindazol-5-yl)ethyl]-2H-1,2,4-oxadiazole-5-thione	Investigative	71664626	C11H10N4O2S	262.29	C1=CC2=C(C=C1CCC3=NC(=S)ON3)C=NN2O	Ki = 70370 nM	Poor binder
T82795	Beta-catenin	BQ9K1R	COC(=O)CCn1c2ccccc2c2nc3nonc3nc12	Investigative	122180638	C14H11N5O3	297.27	COC(=O)CCN1C2=CC=CC=C2C3=NC4=NON=C4N=C31	Ki = 100000 nM	Poor binder
T82795	Beta-catenin	BQD12F	2-(13-Oxa-8,10,12,14,16-pentazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11,14-heptaen-8-yl)acetonitrile	Investigative	122180709	C12H6N6O	250.22	C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3N2CC#N	Ki ~ 130000 nM	Poor binder
T82795	Beta-catenin	BR1WP5	4-(13-Oxa-8,10,12,14,16-pentazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(16),2,4,6,9,11,14-heptaen-8-yl)butanenitrile	Investigative	122180711	C14H10N6O	278.27	C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3N2CCCC#N	Ki = 120000 nM	Poor binder
T82795	Beta-catenin	BS7TX3	4-[(5E)-5-[(3,4-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid	Investigative	1416323	C16H17NO5S2	367.4	COC1=C(C=C(C=C1)/C=C/2\\C(=O)N(C(=S)S2)CCCC(=O)O)OC	Ki = 80000 nM	Poor binder
T82795	Beta-catenin	BW8A1V	1-Hydroxy-5-(2H-tetrazol-5-ylmethyl)benzotriazole	Investigative	71695701	C8H7N7O	217.19	C1=CC2=C(C=C1CC3=NNN=N3)N=NN2O	Ki = 94400 nM	Poor binder
T82795	Beta-catenin	BWM7Y6	3-[(1-Hydroxybenzotriazol-5-yl)methyl]-2H-1,2,4-oxadiazol-5-one	Investigative	136268329	C9H7N5O3	233.18	C1=CC2=C(C=C1CC3=NOC(=O)N3)N=NN2O	Ki = 125100 nM	Poor binder
T82795	Beta-catenin	BXG1L8	1-Hydroxy-5-[2-(2H-tetrazol-1-ium-1-yl)ethyl]benzotriazole	Investigative	123282161	C9H10N7O+	232.22	C1=CC2=C(C=C1CC[N+]3=CN=NN3)N=NN2O	Ki = 54200 nM	Poor binder
T82795	Beta-catenin	BXV97L	Cercosporin, pure	Investigative	360901	C29H26O10	534.5	C[C@@H](CC1=C2C3=C(C(=C(C4=C3C5=C6C2=C(C(=O)C=C6OCOC5=CC4=O)C(=C1OC)O)O)OC)C[C@H](C)O)O	IC50 = 130000 nM	Poor binder
T82795	Beta-catenin	BZ5ND8	1-Hydroxy-5-(2H-tetrazol-5-ylmethoxymethyl)benzotriazole	Investigative	71695704	C9H9N7O2	247.21	C1=CC2=C(C=C1COCC3=NNN=N3)N=NN2O	Ki = 155100 nM	Poor binder
T82795	Beta-catenin	BZE67X	5-[2-(2H-Tetrazol-5-yl)ethyl]-1H-indazole	Investigative	71695774	C10H10N6	214.23	C1=CC2=C(C=C1CCC3=NNN=N3)C=NN2	Ki = 179930 nM	Poor binder